









市场行情
/
股票
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

66.060USD

+0.150+0.23%

收盘 12/19, 16:00（美东）报价延迟15分钟

25.76B总市值

35.86市盈率 TTM



Dexcom Inc

66.060

+0.150+0.23%

概览公司财务分析

概览

公司

财务

分析

关于 Dexcom Inc 公司

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Dexcom Inc简介



公司代码DXCM

公司名称Dexcom Inc

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

员工数量10300

证券类型Ordinary Share

年结日Apr 14

公司地址6340 Sequence Drive

城市SAN DIEGO

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编92121

电话18582000200

网址https://www.dexcom.com/

公司代码DXCM

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Dexcom Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Ms. Bridgette P. Heller

Independent Director

27.03K

-3.61%

Mr. Kyle Malady

Independent Director

22.67K

-2.86%

Ms. Rimma Driscoll

Independent Director

9.04K

+127.87%

Ms. Renee D. Gala

Independent Director

6.88K

+20.30%

名称

名称/职务

职务

持股

持股变动

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

地区USD

名称

营收

占比

United States

841.00M

72.68%

Outside of United states

316.10M

27.32%

业务

地区

业务USD

名称

营收

占比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

股东统计

更新时间: 11月18日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

其他

69.92%

持股股东

占比

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

其他

69.92%

股东类型

持股股东

占比

Investment Advisor

53.37%

Investment Advisor/Hedge Fund

28.82%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.14%

Bank and Trust

1.94%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.37%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

2120

388.08M

103.93%

+205.32K

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

48.15M

12.28%

+859.71K

+1.82%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

24.25M

6.18%

-475.12K

-1.92%

Jun 30, 2025

State Street Investment Management (US)

16.86M

4.3%

+175.27K

+1.05%

Jun 30, 2025

Baillie Gifford & Co.

16.71M

4.26%

+2.53M

+17.81%

Jun 30, 2025

Geode Capital Management, L.L.C.

10.77M

2.75%

+358.62K

+3.45%

Jun 30, 2025

Jennison Associates LLC

11.52M

2.94%

+994.30K

+9.45%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

8.03M

2.05%

-28.35K

-0.35%

Aug 31, 2025

Nuveen LLC

7.30M

1.86%

-549.07K

-7.00%

Jun 30, 2025

MFS Investment Management

6.49M

1.65%

+3.30M

+103.55%

Jun 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

Global X Internet of Things ETF

3.86%

iShares U.S. Medical Devices ETF

2.71%

Motley Fool Global Opportunities ETF

1.9%

First Trust Growth Strength ETF

1.74%

Putnam Sustainable Future ETF

1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.51%

Invesco S&P 500 Equal Weight Health Care ETF

1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

0.83%

iShares Russell Mid-Cap Growth ETF

0.7%

Global X Internet of Things ETF

占比3.86%

iShares U.S. Medical Devices ETF

占比2.71%

Motley Fool Global Opportunities ETF

占比1.9%

First Trust Growth Strength ETF

占比1.74%

Putnam Sustainable Future ETF

占比1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

占比1.51%

Invesco S&P 500 Equal Weight Health Care ETF

占比1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

占比0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

占比0.83%

iShares Russell Mid-Cap Growth ETF

占比0.7%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

Mar 28, 2022

Split

1→4

公告日期

类型

比率

Mar 28, 2022

Split

1→4

常见问题

Dexcom Inc的前五大股东是谁？



Dexcom Inc 的前五大股东如下：
The Vanguard Group, Inc.持有股份：48.15M，占总股份比例：12.28%。
BlackRock Institutional Trust Company, N.A.持有股份：24.25M，占总股份比例：6.18%。
State Street Investment Management (US)持有股份：16.86M，占总股份比例：4.30%。
Baillie Gifford & Co.持有股份：16.71M，占总股份比例：4.26%。
Geode Capital Management, L.L.C.持有股份：10.77M，占总股份比例：2.75%。